Contemporary Prevalence and Treatment Patterns Among US Adults With Apparent Treatment-Resistant Hypertension

医学 入射(几何) 儿科 血压 环境卫生 人口学 流行病学 高血压治疗 梅德林 流行 公共卫生 疾病 老年学 内科学
作者
William Earle,Nathan W. Watson,Stephen P. Juraschek,Jennifer Cluett,Anna Krawisz,Eric A. Secemsky
出处
期刊:Hypertension [Lippincott Williams & Wilkins]
卷期号:83 (6): e25659-e25659 被引量:1
标识
DOI:10.1161/hypertensionaha.125.25659
摘要

BACKGROUND: Resistant hypertension is associated with adverse cardiovascular outcomes and mortality. In the past decade, management guidelines have shifted to target lower blood pressures (BP). Current prevalence and prescribing patterns among adults with resistant hypertension are not well characterized. METHODS: We used data from the National Health and Nutrition Examination Survey from 2003 to 2020. Apparent treatment-resistant hypertension (aTRH) was defined as patients on a diuretic, either with a systolic BP ≥130 or diastolic BP ≥80 mm Hg while on 3 medications or those on ≥4 medications regardless of BP. Medications were identified through pill bottle review. RESULTS: Of 24 579 adults with hypertension , 1939 had aTRH (42.4% male, 19.9% Black), corresponding to a weighted total of 6 989 821 US patients. Among hypertensive adults, the prevalence of aTRH was 6.41% (95% CI, 5.97%-6.88%) and remained stable over time. Over the study duration, aTRH prevalence among adults on treatment decreased from 17.7% to 12.6%. The overall prevalence of hypertension rose from 50.1% to 54.0%, while the prevalence of uncontrolled BP decreased from 75.0% to 68.7%. Over time, use of 3 drug regimens for aTRH decreased (57.8%-42.9%), while 4 drug regimens increased (34.0%-51.8%). aTRH was most strongly associated with older patients, those of Black race, higher body mass index, and more advanced cardiovascular comorbidities. CONCLUSION: The prevalence of aTRH has remained stable over the past 2 decades despite the rising incidence of hypertension . Use of multidrug treatment regimens has increased, aligning with national guidelines. However, uncontrolled hypertension remains high.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
周江阔发布了新的文献求助10
刚刚
刚刚
1秒前
多多发布了新的文献求助10
1秒前
思源的应助被追寻如萱采纳,获得10
1秒前
1秒前
Jello发布了新的文献求助10
2秒前
无极微光的应助被清绘采纳,获得20
2秒前
2秒前
KKZNB发布了新的文献求助10
2秒前
Orange的应助被和谐的雪瑶采纳,获得30
3秒前
逆流的鱼完成签到,获得积分10
4秒前
852的应助被tang采纳,获得10
4秒前
5秒前
molihuakai的应助被Benthesikyme采纳,获得10
5秒前
1st发布了新的文献求助10
5秒前
深情安青的应助被科研通管家采纳,获得10
6秒前
6秒前
Nicu发布了新的文献求助10
6秒前
Jun的应助被科研通管家采纳,获得20
6秒前
上官若男的应助被科研通管家采纳,获得10
6秒前
7秒前
CarryLJR的应助被湖工大保卫处采纳,获得10
7秒前
爆米花的应助被科研通管家采纳,获得10
7秒前
7秒前
小萌兽发布了新的文献求助50
7秒前
Orange的应助被科研通管家采纳,获得10
7秒前
ding的应助被科研通管家采纳,获得10
7秒前
syvshc的应助被nikola采纳,获得10
7秒前
CodeCraft的应助被科研通管家采纳,获得10
7秒前
7秒前
华仔的应助被科研通管家采纳,获得10
7秒前
小二郎的应助被科研通管家采纳,获得10
8秒前
Jasper的应助被科研通管家采纳,获得10
8秒前
科研通AI6.3的应助被Bai采纳,获得10
8秒前
丘比特的应助被科研通管家采纳,获得10
8秒前
情怀的应助被科研通管家采纳,获得10
8秒前
wanci的应助被科研通管家采纳,获得10
8秒前
852的应助被1111采纳,获得10
8秒前
pykw的应助被科研通管家采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178807
求助须知:如何正确求助?哪些是违规求助? 9569558
关于积分的说明 21805222
捐赠科研通 7773974
什么是DOI,文献DOI怎么找? 3432933
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478593